ArticleOdontology2026
Loss of TRPV4 impairs mucin secretion and salivary rheological properties in male mouse sublingual glands.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Transient receptor potential cation channel subfamily V member 4 (TRPV4) is implicated in salivary secretion; however, its role in mucin secretion in mouse sublingual glands (SLGs) remains unclear. This study used an ex vivo perfusion model to investigate the contribution of TRPV4 to mucin secretion and the rheological properties of saliva in wild-type (Trpv4⁺/⁺) and knockout (Trpv4⁻/⁻) male mice (8-12 weeks old) subjected to carbachol stimulation. Mucin content was assessed by N-acetylgalactosamine (GalNAc) fluorescent labeling, viscoelasticity by spinnbarkeit analysis, and MUC19 expression by immunohistochemistry, quantitative PCR, and western blot. Pharmacological TRPV4 inhibition with RN1734 was also performed in Trpv4⁺/⁺ SLGs. Salivary flow rate, pH, Ca²⁺, and total protein concentration were comparable between genotypes. GalNAc concentration and spinnbarkeit were significantly reduced in Trpv4⁻/⁻ SLG saliva, and RN1734 treatment in Trpv4⁺/⁺ SLGs reproduced these reductions. Muc19 mRNA expression and intracellular MUC19 distribution were unaffected, whereas MUC19 protein in secreted saliva was significantly lower in Trpv4⁻/⁻ mice. These findings indicate that TRPV4 contributes to mucin secretion in SLG acinar cells independently of fluid secretion and Muc19 transcriptional regulation, likely at the level of exocytosis.
Indexed as
Identifiers
42321523What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.